GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 11.84B INR in the quarter ending September 30, 2026, with 20.78% growth. This brings the company's total for the last twelve months to 41.59B, up 12.12% year-over-year. In the fiscal year ending March 31, 2026, GlaxoSmithKline Pharmaceuticals had annual revenue of 38.22B with 1.93% growth.

• Revenue (ttm): 41.59B
• Revenue Growth: +12.12%
• P/S Ratio: 11.04
• Revenue / Employee: 13.40M
• Employees: 3,103
• Market Cap: 454.15B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 37.70B 98.6%
• Foreign 520.95M 1.4%

Fiscal year ended Mar 31, 2026 See the full NSE:GLAXO breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	38.22B	724.64M	1.93%
Mar 31, 2025	37.49B	2.96B	8.56%
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error